The Evolution of Autoimmune Hemolytic Anemia Treatment: From Immunosuppressive Therapy to Targeted Biologics
Autoimmune hemolytic anemia (AIHA) is a rare and complex red blood cell disorder where the immune system mistakenly produces antibodies that attack and destroy the body's own red blood cells. This leads to varying degrees of anemia, ranging from mild fatigue to life-threatening hemolytic crises. The management of this condition requires careful diagnosis and a tailored therapeutic approach. The...
0 Commentarii 0 Distribuiri 139 Views 0 previzualizare